相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Behçet’s disease and genes within the major histocompatibility complex region
Yeong Wook Song et al.
Modern Rheumatology (2014)
A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
Toru Hirano et al.
Modern Rheumatology (2014)
Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysis
Shunsei Hirohata et al.
Modern Rheumatology (2014)
Available evidence and outcome of off-label use of rituximab in clinical practice
I. Danes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1
Yohei Kirino et al.
NATURE GENETICS (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Behcet Disease-associated Uveitis Successfully Treated with Golimumab
Marina Mesquida et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease
Yohei Kirino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study
Ahmet Gul et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Identification of a Susceptibility Locus in STAT4 for Behcet's Disease in Han Chinese in a Genome-Wide Association Study
Shengping Hou et al.
ARTHRITIS AND RHEUMATISM (2012)
New insights into the pathogenesis of Behcet's disease
Marc Pineton de Chambrun et al.
AUTOIMMUNITY REVIEWS (2012)
Tocilizumab treatment for neuro-Behcet's disease, the first report
Lee S. Shapiro et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus
Kirsten Fairfax et al.
IUBMB LIFE (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
HLA-B*51 and Behcet Disease
Ahmet Gul et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2012)
Adalimumab for the treatment of Behcet's disease: experience in 19 patients
Daniela Perra et al.
RHEUMATOLOGY (2012)
Long-term Efficacy and Safety of Low-Dose and Dose-Escalating Interferon Alfa-2a Therapy in Refractory Behcet Uveitis
Sumru Onal et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Behcet's syndrome and micro-organisms
Gulen Hatemi et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease
Guillaume Geri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
IFN-α blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease
Xiaoli Liu et al.
RHEUMATOLOGY (2011)
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs
AnnaRita Giardina et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Genetics of Behcet disease inside and outside the MHC
Akira Meguro et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)
Fereydoun Davatchi et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease
Elaine F. Remmers et al.
NATURE GENETICS (2010)
Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behcet disease with pulmonary involvement
Agnes Hamzaoui et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Phenotype and functional changes of V gamma 9/V delta 2 T lymphocytes in Behcet's disease and the effect of infliximab on V gamma 9/V delta 2 T cell expansion, activation and cytotoxicity
Antonina Accardo-Palumbo et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Effects of anti-TNF- antibody infliximab in refractory entero-Behets disease
Shigeru Iwata et al.
RHEUMATOLOGY (2009)
Resistant Behcet disease responsive to anakinra
Costantino Botsios et al.
ANNALS OF INTERNAL MEDICINE (2008)
BAFF is up-regulated in central nervous system of neuro-Behcet's disease
Kamel Hamzaoui et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Tocilizumab may be a potential addition to our weapons against neuro-Behcet's disease
Afshin Borhani-Haghighi et al.
MEDICAL HYPOTHESES (2008)
Relationship between periodontal findings and specific polymorphisms of interleukin-1 alpha and -1 beta in Turkish patients with Behcet's disease
Ayse Akman et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2008)
The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease
O. Shaker et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells
Salih Pay et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Results of interferon-alfa therapy in patients with Behcet uveitis
Ilknur Tugal-Tutkun et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behcet's disease.: Does interleukin-1β play a major role in Behcet's synovitis?
S Pay et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Diversity of γδ T cells in patients with Behcet's disease is indicative of polyclonal activation
J. Freysdottir et al.
ORAL DISEASES (2006)
Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease
S Buldanlioglu et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques
M Benagiano et al.
JOURNAL OF IMMUNOLOGY (2005)
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
ES Day et al.
BIOCHEMISTRY (2005)
Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behcet's disease
B Adam et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease
J Karasneh et al.
RHEUMATOLOGY (2003)
Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis
I Kötter et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
V gamma 9/V delta 2 T lymphocytes in Italian patients with Behcet's disease - evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta(1) expression in active disease
G Triolo et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Expansion of gamma delta T-cells in Behcet's disease: Role of disease activity and microbial flora in oral ulcers
I Bank et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
Interferon alfa-2a in the treatment of Behcet disease - A randomized placebo-controlled and double-blind study
E Alpsoy et al.
ARCHIVES OF DERMATOLOGY (2002)
分享论文
